Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A02521 | 34342168 | Physiol Rep | Hormonal regulation of glycine decarboxylase and its relationship to oxidative stress. | 2021 | Details |
| A02532 | 34339764 | J Hepatol | Prevention of NAFLD-associated HCC: Role of lifestyle and chemoprevention. | 2021 | Details |
| A02535 | 34337376 | Metabol Open | The role of zinc in the prevention and treatment of nonalcoholic fatty liver disease. | 2021 | Details |
| A02554 | 34330456 | Clin Nutr ESPEN | Effect of omega-3 supplementation on fatty liver and visceral adiposity indices in diabetic patients with non-alcoholic fatty liver disease: A randomized controlled trial. | 2021 | Details |
| A02561 | 34328120 | Biomed Pharmacother | Molecular mechanism of DLBS3733, a bioactive fraction of Lagerstroemia speciosa (L.) Pers., on ameliorating hepatic lipid accumulation in HepG2 cells. | 2021 | Details |
| A02565 | 34327498 | Am J Prev Cardiol | Health disparities in cardiometabolic risk among Black and Hispanic youth in the United States. | 2021 | Details |
| A02567 | 34326946 | World J Diabetes | Exploring new treatment options for polycystic ovary syndrome: Review of a novel antidiabetic agent SGLT2 inhibitor. | 2021 | Details |
| A02573 | 34326098 | BMJ Open Gastroenterol | Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease. | 2021 | Details |
| A02585 | 34322121 | Front Immunol | CD8+ T Cells Involved in Metabolic Inflammation in Visceral Adipose Tissue and Liver of Transgenic Pigs. | 2021 | Details |
| A02597 | 34320238 | Hepatology | SIMPLE Is an Endosomal Regulator That Protects Against NAFLD by Targeting the Lysosomal Degradation of EGFR. | 2021 | Details |
| A02598 | 34320173 | Am J Clin Nutr | The effects of resveratrol supplementation in patients with type 2 diabetes, metabolic syndrome, and nonalcoholic fatty liver disease: an umbrella review of meta-analyses of randomized controlled trials. | 2021 | Details |
| A02601 | 34314787 | Adv Drug Deliv Rev | Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis. | 2021 | Details |
| A02603 | 34312684 | J Mol Med (Berl) | Lipid metabolism, inflammation, and foam cell formation in health and metabolic disorders: targeting mTORC1. | 2021 | Details |
| A02606 | 34311531 | Biomed Pharmacother | FTZ attenuates liver steatosis and fibrosis in the minipigs with type 2 diabetes by regulating the AMPK signaling pathway. | 2021 | Details |
| A02609 | 34311022 | Diabetes Res Clin Pract | Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomised trial. | 2021 | Details |
| A02614 | 34309471 | Ann Med | Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD). | 2021 | Details |
| A02622 | 34306045 | PPAR Res | Activation of the Peroxisome Proliferator-Activated Receptors (PPAR-α/γ) and the Fatty Acid Metabolizing Enzyme Protein CPT1A by Camel Milk Treatment Counteracts the High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02638 | 34299336 | Int J Mol Sci | Non-Coding RNAs: Novel Players in Insulin Resistance and Related Diseases. | 2021 | Details |
| A02655 | 34295993 | Clin Exp Hepatol | Comparative analysis of metabolic risk factors for progression of non-alcoholic fatty liver disease. | 2021 | Details |
| A02657 | 34295984 | Clin Exp Hepatol | Pemafibrate improves hepatic inflammation, function and fibrosis in patients with non-alcoholic fatty liver disease: a one-year observational study. | 2021 | Details |
| A02663 | 34293421 | Ann Epidemiol | Does NAFLD mediate the relationship between obesity and type 2 diabetes risk? evidence from the multi-ethnic study of atherosclerosis (MESA). | 2021 | Details |
| A02678 | 34288580 | United European Gastroenterol J | Impact of thyroid disorders on the incidence of non-alcoholic fatty liver disease in Germany. | 2021 | Details |
| A02684 | 34284789 | Nutr Metab (Lond) | Modulation and bioinformatics screening of hepatic mRNA-lncRNAs (HML) network associated with insulin resistance in prediabetic and exercised mice. | 2021 | Details |
| A02696 | 34279787 | Arch Pharm Res | Aldose Reductase: a cause and a potential target for the treatment of diabetic complications. | 2021 | Details |
| A02698 | 34279027 | Eur J Prev Cardiol | Incremental prognostic value of non-alcoholic fatty liver disease over coronary computed tomography angiography findings in patients with suspected coronary artery disease. | 2022 | Details |
| A02699 | 34278728 | Physiol Rep | Lean non-alcoholic fatty liver disease and associated metabolic disturbance: A Saudi Arabian cross-sectional study. | 2021 | Details |
| A02700 | 34278170 | Hepatol Commun | Colonoscopy and Risk of Colorectal Cancer in Patients With Nonalcoholic Fatty Liver Disease: A Retrospective Territory-Wide Cohort Study. | 2021 | Details |
| A02730 | 34269534 | Korean J Radiol | Quantitative MRI Assessment of Pancreatic Steatosis Using Proton Density Fat Fraction in Pediatric Obesity. | 2021 | Details |
| A02746 | 34262313 | Diabetes Metab Syndr Obes | Liver Stiffness Measurement by Using Transient Elastography in Bangladeshi Patients with Type 2 Diabetes Mellitus and Ultrasonography-Diagnosed Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02753 | 34259033 | J Am Heart Assoc | Elevated Fatty Liver Index Is Independently Associated With New Onset of Hypertension During a 10-Year Period in Both Male and Female Subjects. | 2021 | Details |
| A02754 | 34258604 | Med (N Y) | A genome-first approach to mortality and metabolic phenotypes in MTARC1 p.Ala165Thr (rs2642438) heterozygotes and homozygotes. | 2021 | Details |
| A02757 | 34257694 | Evid Based Complement Alternat Med | Alleviative Effect of Ruellia tuberosa L. on Insulin Resistance and Abnormal Lipid Accumulation in TNF-α-Treated FL83B Mouse Hepatocytes. | 2021 | Details |
| A02764 | 34253010 | Diabetes Metab J | Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus. | 2021 | Details |
| A02775 | 34248137 | Med Sci Monit | Editorial: International Consensus Recommendations to Replace the Terminology of Non-Alcoholic Fatty Liver Disease (NAFLD) with Metabolic-Associated Fatty Liver Disease (MAFLD). | 2021 | Details |
| A02787 | 34240649 | Int J Immunopathol Pharmacol | Allopurinol ameliorates liver injury in type 1 diabetic rats through activating Nrf2. | 2022 | Details |
| A02788 | 34239714 | Oman Med J | Effect of SGLT-2 Inhibitors on Non-alcoholic Fatty Liver Disease among Patients with Type 2 Diabetes Mellitus: Systematic Review with Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials. | 2021 | Details |
| A02791 | 34239263 | World J Gastroenterol | Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements. | 2021 | Details |
| A02801 | 34234538 | Int J Gen Med | Correlation Between 25 Hydroxyvitamin D Levels and Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study. | 2021 | Details |
| A02827 | 34227216 | Diabetes Obes Metab | Impact of SGLT2 inhibitors in comparison with DPP4 inhibitors on ascites and death in veterans with cirrhosis on metformin. | 2021 | Details |
| A02830 | 34226630 | Sci Rep | The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases. | 2021 | Details |
| A02831 | 34226120 | Nutr Metab Cardiovasc Dis | Insulin resistance and NAFLD may influence memory performance in obese patients with prediabetes or newly-diagnosed type 2 diabetes. | 2021 | Details |
| A02838 | 34224699 | Eur J Pharmacol | Dapagliflozin attenuates steatosis in livers of high-fat diet-induced mice and oleic acid-treated L02 cells via regulating AMPK/mTOR pathway. | 2021 | Details |
| A02848 | 34220701 | Front Endocrinol (Lausanne) | Effect of SGLT2 Inhibitors on Type 2 Diabetes Mellitus With Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials. | 2021 | Details |
| A02850 | 34219361 | Liver Int | PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH. | 2021 | Details |
| A02853 | 34219018 | J Diabetes Complications | The prevalence of gestational diabetes mellitus in women diagnosed with non-alcoholic fatty liver disease during pregnancy: A systematic review and meta-analysis. | 2021 | Details |
| A02857 | 34214406 | Expert Opin Investig Drugs | Anti-diabetic drugs and NASH: from current options to promising perspectives. | 2021 | Details |
| A02861 | 34213749 | Indian J Gastroenterol | Comparison of clinical and metabolic profiles of lean versus non-lean nonalcoholic fatty liver disease. | 2021 | Details |
| A02867 | 34211743 | Curr Health Sci J | Assessment of Left Ventricular Diastolic Function in Young Adults with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02868 | 34211711 | SAGE Open Med | Frequency and risk factors of non-alcoholic fatty liver disease in Helicobacter pylori-infected dyspeptic patients: A cross-sectional study. | 2021 | Details |
| A02871 | 34211157 | Nat Rev Gastroenterol Hepatol | New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology. | 2021 | Details |
| A02872 | 34211098 | Commun Biol | Deletion of the diabetes candidate gene Slc16a13 in mice attenuates diet-induced ectopic lipid accumulation and insulin resistance. | 2021 | Details |
| A02931 | 34192792 | Horm Metab Res | Hepatic-Metabolite-Based Intermittent Fasting Enables a Sustained Reduction in Insulin Resistance in Type 2 Diabetes and Metabolic Syndrome. | 2021 | Details |
| A02933 | 34192533 | Cell Rep | Hepatocyte membrane potential regulates serum insulin and insulin sensitivity by altering hepatic GABA release. | 2021 | Details |
| A02934 | 34192532 | Cell Rep | A critical role of hepatic GABA in the metabolic dysfunction and hyperphagia of obesity. | 2021 | Details |
| A02938 | 34190778 | Arq Gastroenterol | EVALUATION OF REST ENERGY EXPENDITURE IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE. | 2021 | Details |
| A02940 | 34190318 | J Clin Endocrinol Metab | Intact Fasting Insulin Identifies Nonalcoholic Fatty Liver Disease in Patients Without Diabetes. | 2021 | Details |
| A02957 | 34184611 | Ann Med | Association between the liver fat score (LFS) and cardiovascular diseases in the national health and nutrition examination survey 1999-2016. | 2021 | Details |
| A02962 | 34183428 | Diabetes Care | Circulating Thrombospondin-2 as a Novel Fibrosis Biomarker of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes. | 2021 | Details |
| A02964 | 34183247 | J Diabetes Complications | Non-invasive diagnosis of nonalcoholic fatty liver disease in patients with type 2 diabetes. | 2021 | Details |
| A02968 | 34179738 | JHEP Rep | Embedding assessment of liver fibrosis into routine diabetic review in primary care. | 2021 | Details |
| A02974 | 34177796 | Front Endocrinol (Lausanne) | Sodium-Glucose Cotransporter-2 Inhibitors Ameliorate Liver Enzyme Abnormalities in Korean Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02987 | 34173917 | Dig Dis Sci | Impact of Fibrosis-4 Index Prior to COVID-19 on Outcomes in Patients at Risk of Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A02990 | 34171957 | Vnitr Lek | The use of moxonidine in the treatment of arterial hypertension. | 2021 | Details |
| A03002 | 34168429 | Drug Des Devel Ther | Metformin in Combination with Malvidin Prevents Progression of Non-Alcoholic Fatty Liver Disease via Improving Lipid and Glucose Metabolisms, and Inhibiting Inflammation in Type 2 Diabetes Rats. | 2021 | Details |
| A03005 | 34168043 | BMJ Open Gastroenterol | Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD). | 2021 | Details |
| A03019 | 34161185 | Autophagy | Autophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective. | 2021 | Details |
| A03022 | 34160360 | Turk J Gastroenterol | The Changing Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) in Turkey in the Last Decade. | 2021 | Details |
| A03023 | 34160089 | J Gastroenterol Hepatol | Low skeletal muscle mass is associated with liver fibrosis in individuals with type 2 diabetes and nonalcoholic fatty liver disease. | 2021 | Details |
| A03037 | 34155821 | Pediatr Obes | Elevated transaminases potentiate the risk for emerging dysglycemia in children with overweight and obesity. | 2021 | Details |
| A03040 | 34155798 | Liver Int | Non-alcoholic fatty liver disease in type 2 diabetes - A specific entity? | 2021 | Details |
| A03041 | 34155794 | Liver Int | New drugs for NASH. | 2021 | Details |
| A03047 | 34154037 | J Gastroenterol Hepatol | Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease. | 2021 | Details |
| A03061 | 34147478 | Eur J Pharmacol | Sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease. | 2021 | Details |
| A03065 | 34146602 | Diabetes Res Clin Pract | Glycemic variability and the risk of nonalcoholic fatty liver disease : A nationwide population-based cohort study. | 2021 | Details |
| A03066 | 34145341 | Sci Rep | High level of fatty liver index predicts new onset of diabetes mellitus during a 10-year period in healthy subjects. | 2021 | Details |
| A03076 | 34139927 | Pharm Biol | Tocopheryl quinone improves non-alcoholic steatohepatitis (NASH) associated dysmetabolism of glucose and lipids by upregulating the expression of glucagon-like peptide 1 (GLP-1) via restoring the balance of intestinal flora in rats. | 2021 | Details |
| A03100 | 34131333 | Nat Rev Endocrinol | Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus. | 2021 | Details |
| A03102 | 34130693 | Lipids Health Dis | Association between nonalcoholic fatty liver disease and incident diabetes mellitus among Japanese: a retrospective cohort study using propensity score matching. | 2021 | Details |
| A03104 | 34129693 | Hepatology | Thiazolidinediones and Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study. | 2021 | Details |
| A03106 | 34129252 | J Gastroenterol Hepatol | The effects of dapagliflozin on hepatic and visceral fat in type 2 diabetes patients with non-alcoholic fatty liver disease. | 2021 | Details |
| A03116 | 34124059 | Front Cell Dev Biol | Pathological Crosstalk Between Oxidized LDL and ER Stress in Human Diseases: A Comprehensive Review. | 2021 | Details |
| A03117 | 34123670 | Cureus | Effect of Dapagliflozin on Type 2 Diabetes Mellitus With Nonalcoholic Fatty Liver Disease: A Single-Center Survey. | 2021 | Details |
| A03156 | 34107939 | BMC Endocr Disord | A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time. | 2021 | Details |
| A03163 | 34106786 | Am J Physiol Cell Physiol | Impaired Ca2+ signaling due to hepatic steatosis mediates hepatic insulin resistance in Alström syndrome mice that is reversed by GLP-1 analog treatment. | 2021 | Details |
| A03189 | 34095297 | Biomed Res Int | A Prediction Model Based on Noninvasive Indicators to Predict the 8-Year Incidence of Type 2 Diabetes in Patients with Nonalcoholic Fatty Liver Disease: A Population-Based Retrospective Cohort Study. | 2021 | Details |
| A03196 | 34093184 | Front Pharmacol | Bicyclol Regulates Hepatic Gluconeogenesis in Rats with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease by Inhibiting Inflammation. | 2021 | Details |
| A03197 | 34093169 | Front Pharmacol | Dapagliflozin Alleviates Hepatic Steatosis by Restoring Autophagy via the AMPK-mTOR Pathway. | 2021 | Details |
| A03202 | 34091530 | Chin Med J (Engl) | Cardiovascular and renal burdens of metabolic associated fatty liver disease from serial US national surveys, 1999-2016. | 2021 | Details |
| A03218 | 34083571 | Sci Rep | High FIB4 index is an independent risk factor of diabetic kidney disease in type 2 diabetes. | 2021 | Details |
| A03221 | 34082056 | Diabetes Res Clin Pract | Feasibility and efficiency of European guidelines for NAFLD assessment in patients with type 2 diabetes: A prospective study. | 2021 | Details |
| A03222 | 34082054 | Diabetes Res Clin Pract | Significant liver fibrosis, as assessed by fibroscan, is independently associated with chronic vascular complications of type 2 diabetes: A multicenter study. | 2021 | Details |
| A03224 | 34081733 | PLoS One | Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017-2018. | 2021 | Details |
| A03228 | 34080327 | J Cachexia Sarcopenia Muscle | Non-alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey. | 2021 | Details |
| A03230 | 34079318 | Diabetes Metab Syndr Obes | Association Between Thyroid Hormone Levels and Advanced Liver Fibrosis in Patients with Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A03235 | 34077443 | PLoS One | Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes. | 2021 | Details |
| A03257 | 34069012 | Int J Environ Res Public Health | Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors. | 2021 | Details |
| A03271 | 34065108 | Int J Mol Sci | Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC. | 2021 | Details |
| A03280 | 34062716 | Int J Mol Sci | Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review. | 2021 | Details |
| A03281 | 34062584 | Dtsch Med Wochenschr | [Alpha-1 antitrypsin deficiency: cause and cofactor for liver disease]. | 2021 | Details |
| A03289 | 34059612 | Curr Opin Cardiol | Update on cardiovascular risk in nonalcoholic fatty liver disease. | 2021 | Details |